Differentiated thyroid cancer and selenium supplements for protection of salivary glands from 131I treatment

被引：0
|
作者：
Mazokopakis, Elias E. [1 ]
机构：
[1] Naval Hosp Crete, Dept Internal Med, Khania 73200, Crete, Greece
来源：
HELLENIC JOURNAL OF NUCLEAR MEDICINE | 2018年 / 21卷 / 01期
关键词：
HASHIMOTOS-THYROIDITIS; MANAGEMENT;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [41] DETERMINATION OF DISTRIBUTION OF 131I IN BIOSYNTHETICALLY LABELLED [131I] TRI-IODOTHYRONINE ISOLATED FROM THYROID GLANDS OF RABBITS
    PLASKETT, LG
    BIOCHEMICAL JOURNAL, 1961, 78 (03) : 657 - &
  • [42] The feasibility of dose estimation to thyroid remnants and salivary glands and avid following therapeutic 131I administration
    Abuqbeitah, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S47 - S47
  • [43] Radiation protection from patients with thyroid diseases treated by 131I
    Liu, Bin
    Kuang, Anren
    Rong, Tian
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [44] Dosimetry of high-dose treatment with 131I in differentiated thyroid cancer -: Evaluation by PET and 124I.
    Eschmann, SM
    Thelen, MH
    Reischl, G
    Zagar, I
    Dohmen, BM
    Coenen, HH
    Machulla, HJ
    Bares, R
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 84P - 84P
  • [45] Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma
    Verburg, Frederik A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 253 - 257
  • [46] Curative Efficacy and Influencing Factors on 131I Treatment for Pulmonary Metastases from Differentiated Thyroid Carcinoma
    Xu, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S601 - S602
  • [47] A comparative study of the protective effect of vitamin C and amifostine to salivary gland function of differentiated thyroid cancer in 131I therapy
    Wang, Cong
    Fan, Ningfagn
    Liu, Jianzhong
    Jin Jianhua
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [48] The efficiency of planning of therapeutic 131I activities in the radioiodine therapy of differentiated thyroid cancer
    Sinyuta, B
    Dzhuzha, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1004 - 1004
  • [49] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
  • [50] 131I SPECT/CT provides prognostic information in patients with differentiated thyroid cancer
    Heinrich, Marieke
    Blickle, Elias
    Hartrampf, Philipp E.
    Hasenauer, Natalie
    Kosmala, Aleksander
    Kerscher, Alexander
    Schlegel, Nicolas
    Verburg, Frederik A.
    Buck, Andreas K.
    Michalski, Kerstin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
12345